NASDAQ:PRTK
Paratek Pharma
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
paratekpharma.comipo date
Feb 03, 2009
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus